Abbonarsi

Association between radiographic and functional outcome in vertebral osteomyelitis SPONDIMMO, a 6-month prospective multicenter cohort - 30/11/23

Doi : 10.1016/j.jbspin.2023.105600 
Marie Chevalerias a, , Guillaume Coiffier b, Christelle Darrieutort-Laffite a, Sophie Godot c, Sebastien Ottaviani d, Julien Henry e, Julia Brochard f, Grégoire Cormier g, Marion Couderc h, Emmanuel Hoppe i, Denis Mulleman j, Lydie Khatchatourian k, Aurélie Le Thuaut l, Géraldine Bart m, Benoit Le Goff a
a Department of Rheumatology, CHU de Nantes, Nantes, France 
b Department of Rheumatology, CH de Saint-Malo, Saint-Malo, France 
c Department of Rheumatology, AP–HP DCSS, Paris, France 
d Department of Rheumatology, AP–HP Bichat, Paris, France 
e Department of Rheumatology, AP–HP Bicêtre, Paris, France 
f Department of Infectious Diseases, CH de Saint-Nazaire, Saint-Nazaire, France 
g Department of Rheumatology, CHD de Vendée, La Roche-sur-Yon, France 
h Department of Rheumatology, CHU de Clermont-Ferrand, Clermont-Ferrand, France 
i Department of Rheumatology, CHU d’Angers, Angers, France 
j Department of Rheumatology, CHU de Tours, Tours, France 
k Department of Internal Medicine and Infectious Disease, CH de Cornouaille, Quimper, France 
l Direction of Research, Methodology and Biostatistics Platform, CHU de Nantes, Nantes, France 
m Department of Rheumatology and Internal Medicine, Percy Military Training Hospital, Paris, France 

Corresponding author.

Highlights

After 3 months, all the radiographic features worsened.
Between 3 and 6 months, among the different X-ray abnormalities, only the complete fusion progressed.
Sixteen percent of the patients with vertebral osteomyelitis (VO) still present with a severe to major disability at 6 months.
Vertebral destruction was associated with a higher disability at 6 months.
No differences in radiological progression were observed depending on immobilization.

Il testo completo di questo articolo è disponibile in PDF.

Abstract

Objectives

This study aimed to describe radiographic and functional evolution over 6 months in a large cohort of VO patients.

Methods

We prospectively recruited patients with VO from 2016 to 2019 in 11 French centers. X-rays were performed at baseline, 3 months, and 6 months to assess progression using structural and static criteria. Functional impairment was evaluated using the Oswestry Disability Index (ODI) at 3 months and 6 months.

Results

Two hundred and twenty-two patients were included. Mean age was 67.8±14 years, mostly men (67.6%). After 3 months, there was a significant increase in vertebral fusion (16.4% vs 52.7%), destruction of vertebral bodies (10.1% vs 22.8%), and of all the static features (frontal angulation (15.2% vs 24.4%), segmental (34.6% vs 56%) and regional (24.5% vs 41%) kyphosis). From 3 to 6 months, among the different X-ray abnormalities, only the complete fusion progressed significantly (16.6% vs 27.2%). Median ODI showed significant improvement from 3 to 6 months (24, IQR [11.5–38] vs 16, IQR [6–34]). At 6 months, 14.1% of the patients had a severe disability, 2% a major disability. The persistence of vertebral destruction at 6 months was associated with a higher ODI (16, IQR [7.5–30.5] vs 27, IQR [11.5–44.5]). No differences in radiological progression were observed with immobilization using a rigid brace.

Conclusion

Our study demonstrates structural and static radiographic progression after 3 months. Only the complete fusion progressed over the long-term. Functional impairment was associated with persistence of vertebral destruction.

Il testo completo di questo articolo è disponibile in PDF.

Keywords : Vertebral osteomyelitis, Spondylodiscitis, X-ray, Radiography, Follow-up


Mappa


© 2023  Société française de rhumatologie. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 90 - N° 6

Articolo 105600- dicembre 2023 Ritorno al numero
Articolo precedente Articolo precedente
  • Zoledronate and osteonecrosis of the jaw in osteoporosis: incidence and risk factors. Analysis of the French Pharmacovigilance Database
  • Claire Amigues, Audrey Fresse, Christian Hubert Roux, Sophie Gauthier, Marie-Hélène Vieillard, Milou-Daniel Drici, Véronique Breuil, French Network of Pharmacovigilance Centers
| Articolo seguente Articolo seguente
  • Bisphosphonate treatment in inaccessible osteoid osteomas: An alternative therapeutic approach
  • Guillaume Larid, Simon Valayer, Clémentine Jacquier, Pierre Lafforgue, Jean Denis Laredo, Thao Pham

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.